Point-of-care manufacturing of fresh CAR T cell therapy for a phase II non-inferiority study in relapsed/refractory diffuse large B cell lymphoma
- Gareb, B. (Invited speaker)
Activity: Talk and presentation › Academic presentation › Academic
Activity: Talk and presentation › Academic presentation › Academic